Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study
IRVINE, Calif., Dec. 04, 2024 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding

